Dimethandrolone dodecylcarbonate

Dimethandrolone dodecylcarbonate (developmental code name CDB-4730), or dimethandrolone dodecanoylcarbonate, also known as 7α,11β-dimethyl-19-nortestosterone 17β-dodecylcarbonate, is a synthetic and orally active anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was developed by the Contraceptive Development Branch (CDB) of the National Institute of Child Health and Human Development (NICHD) and has not been marketed at this time.[1] It is an androgen ester – specifically, the C17β dodecylcarbonate ester of dimethandrolone (7α,11β-dimethyl-19-nortestosterone) – and acts as a prodrug of dimethandrolone in the body.[1]

Dimethandrolone dodecylcarbonate
Clinical data
Other namesCDB-4730; Dimethandrolone dodecanoylcarbonate; Dimethandrolone 17β-dodecylcarbonate; 7α,11β-Dimethyl-19-nortestosterone 17β-dodecylcarbonate
Routes of
administration
By mouth, intramuscular injection[1]
Drug classAndrogen; Anabolic steroid; Progestogen
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
FormulaC33H54O4
Molar mass514.7795 g/mol g·mol−1
3D model (JSmol)

See also

References

  1. Blye, Richard P., and Hyun K. Kim. "Nandrolone 17β-carbonates." U.S. Patent No. 7,820,642. 26 Oct. 2010.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.